Phage Therapy-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data
Report Summary
Phage Therapy-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data offers a comprehensive analysis on Phage Therapy industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Phage Therapy 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Phage Therapy worldwide and market share by regions, with company and product introduction, position in the Phage Therapy market
Market status and development trend of Phage Therapy by types and applications
Cost and profit status of Phage Therapy, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Phage Therapy market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Phage Therapy industry.
The report segments the global Phage Therapy market as:
Global Phage Therapy Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Phage Therapy Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Global Phage Therapy Market: Application Segment Analysis (Consumption Volume and Market Share 206-2026; Downstream Customers and Market Analysis)
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Global Phage Therapy Market: Manufacturers Segment Analysis (Company and Product introduction, Phage Therapy Sales Volume, Revenue, Price and Gross Margin):
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Phage Therapy-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data offers a comprehensive analysis on Phage Therapy industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Phage Therapy 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Phage Therapy worldwide and market share by regions, with company and product introduction, position in the Phage Therapy market
Market status and development trend of Phage Therapy by types and applications
Cost and profit status of Phage Therapy, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Phage Therapy market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Phage Therapy industry.
The report segments the global Phage Therapy market as:
Global Phage Therapy Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Phage Therapy Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Global Phage Therapy Market: Application Segment Analysis (Consumption Volume and Market Share 206-2026; Downstream Customers and Market Analysis)
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Global Phage Therapy Market: Manufacturers Segment Analysis (Company and Product introduction, Phage Therapy Sales Volume, Revenue, Price and Gross Margin):
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PHAGE THERAPY
1.1 Definition of Phage Therapy in This Report
1.2 Commercial Types of Phage Therapy
1.2.1 DsDNA Bacteriophage
1.2.2 SsDNA Bacteriophage
1.2.3 SsRNA Bacteriophage
1.2.4 Others
1.3 Downstream Application of Phage Therapy
1.3.1 Animal Health
1.3.2 Aquaculture
1.3.3 Agriculture
1.3.4 Food Industry
1.3.5 Human Health
1.3.6 Others
1.4 Development History of Phage Therapy
1.5 Market Status and Trend of Phage Therapy 2016-2026
1.5.1 Global Phage Therapy Market Status and Trend 2016-2026
1.5.2 Regional Phage Therapy Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Phage Therapy 2016-2021
2.2 Sales Market of Phage Therapy by Regions
2.2.1 Sales Volume of Phage Therapy by Regions
2.2.2 Sales Value of Phage Therapy by Regions
2.3 Production Market of Phage Therapy by Regions
2.4 Global Market Forecast of Phage Therapy 2022-2026
2.4.1 Global Market Forecast of Phage Therapy 2022-2026
2.4.2 Market Forecast of Phage Therapy by Regions 2022-2026
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Phage Therapy by Types
3.2 Sales Value of Phage Therapy by Types
3.3 Market Forecast of Phage Therapy by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Phage Therapy by Downstream Industry
4.2 Global Market Forecast of Phage Therapy by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Phage Therapy Market Status by Countries
5.1.1 North America Phage Therapy Sales by Countries (2016-2021)
5.1.2 North America Phage Therapy Revenue by Countries (2016-2021)
5.1.3 United States Phage Therapy Market Status (2016-2021)
5.1.4 Canada Phage Therapy Market Status (2016-2021)
5.1.5 Mexico Phage Therapy Market Status (2016-2021)
5.2 North America Phage Therapy Market Status by Manufacturers
5.3 North America Phage Therapy Market Status by Type (2016-2021)
5.3.1 North America Phage Therapy Sales by Type (2016-2021)
5.3.2 North America Phage Therapy Revenue by Type (2016-2021)
5.4 North America Phage Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Phage Therapy Market Status by Countries
6.1.1 Europe Phage Therapy Sales by Countries (2016-2021)
6.1.2 Europe Phage Therapy Revenue by Countries (2016-2021)
6.1.3 Germany Phage Therapy Market Status (2016-2021)
6.1.4 UK Phage Therapy Market Status (2016-2021)
6.1.5 France Phage Therapy Market Status (2016-2021)
6.1.6 Italy Phage Therapy Market Status (2016-2021)
6.1.7 Russia Phage Therapy Market Status (2016-2021)
6.1.8 Spain Phage Therapy Market Status (2016-2021)
6.1.9 Benelux Phage Therapy Market Status (2016-2021)
6.2 Europe Phage Therapy Market Status by Manufacturers
6.3 Europe Phage Therapy Market Status by Type (2016-2021)
6.3.1 Europe Phage Therapy Sales by Type (2016-2021)
6.3.2 Europe Phage Therapy Revenue by Type (2016-2021)
6.4 Europe Phage Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Phage Therapy Market Status by Countries
7.1.1 Asia Pacific Phage Therapy Sales by Countries (2016-2021)
7.1.2 Asia Pacific Phage Therapy Revenue by Countries (2016-2021)
7.1.3 China Phage Therapy Market Status (2016-2021)
7.1.4 Japan Phage Therapy Market Status (2016-2021)
7.1.5 India Phage Therapy Market Status (2016-2021)
7.1.6 Southeast Asia Phage Therapy Market Status (2016-2021)
7.1.7 Australia Phage Therapy Market Status (2016-2021)
7.2 Asia Pacific Phage Therapy Market Status by Manufacturers
7.3 Asia Pacific Phage Therapy Market Status by Type (2016-2021)
7.3.1 Asia Pacific Phage Therapy Sales by Type (2016-2021)
7.3.2 Asia Pacific Phage Therapy Revenue by Type (2016-2021)
7.4 Asia Pacific Phage Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Phage Therapy Market Status by Countries
8.1.1 Latin America Phage Therapy Sales by Countries (2016-2021)
8.1.2 Latin America Phage Therapy Revenue by Countries (2016-2021)
8.1.3 Brazil Phage Therapy Market Status (2016-2021)
8.1.4 Argentina Phage Therapy Market Status (2016-2021)
8.1.5 Colombia Phage Therapy Market Status (2016-2021)
8.2 Latin America Phage Therapy Market Status by Manufacturers
8.3 Latin America Phage Therapy Market Status by Type (2016-2021)
8.3.1 Latin America Phage Therapy Sales by Type (2016-2021)
8.3.2 Latin America Phage Therapy Revenue by Type (2016-2021)
8.4 Latin America Phage Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Phage Therapy Market Status by Countries
9.1.1 Middle East and Africa Phage Therapy Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Phage Therapy Revenue by Countries (2016-2021)
9.1.3 Middle East Phage Therapy Market Status (2016-2021)
9.1.4 Africa Phage Therapy Market Status (2016-2021)
9.2 Middle East and Africa Phage Therapy Market Status by Manufacturers
9.3 Middle East and Africa Phage Therapy Market Status by Type (2016-2021)
9.3.1 Middle East and Africa Phage Therapy Sales by Type (2016-2021)
9.3.2 Middle East and Africa Phage Therapy Revenue by Type (2016-2021)
9.4 Middle East and Africa Phage Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PHAGE THERAPY
10.1 Global Economy Situation and Trend Overview
10.2 Phage Therapy Downstream Industry Situation and Trend Overview
CHAPTER 11 PHAGE THERAPY MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Phage Therapy by Major Manufacturers
11.2 Production Value of Phage Therapy by Major Manufacturers
11.3 Basic Information of Phage Therapy by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Phage Therapy Major Manufacturer
11.3.2 Employees and Revenue Level of Phage Therapy Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PHAGE THERAPY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 NPO Microgen
12.1.1 Company profile
12.1.2 Representative Phage Therapy Product
12.1.3 Phage Therapy Sales, Revenue, Price and Gross Margin of NPO Microgen
12.2 Proteon Pharmaceuticals
12.2.1 Company profile
12.2.2 Representative Phage Therapy Product
12.2.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Proteon Pharmaceuticals
12.3 Phagelux
12.3.1 Company profile
12.3.2 Representative Phage Therapy Product
12.3.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Phagelux
12.4 Intralytix
12.4.1 Company profile
12.4.2 Representative Phage Therapy Product
12.4.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Intralytix
12.5 Micreos
12.5.1 Company profile
12.5.2 Representative Phage Therapy Product
12.5.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Micreos
12.6 Eliava BioPreparations
12.6.1 Company profile
12.6.2 Representative Phage Therapy Product
12.6.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Eliava BioPreparations
12.7 Locus Biosciences,Inc
12.7.1 Company profile
12.7.2 Representative Phage Therapy Product
12.7.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Locus Biosciences,Inc
12.8 Pharmex Group,LLC
12.8.1 Company profile
12.8.2 Representative Phage Therapy Product
12.8.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Pharmex Group,LLC
12.9 Pherecydes Pharma
12.9.1 Company profile
12.9.2 Representative Phage Therapy Product
12.9.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Pherecydes Pharma
12.10 APS Biocontrol Ltd. (APS)
12.10.1 Company profile
12.10.2 Representative Phage Therapy Product
12.10.3 Phage Therapy Sales, Revenue, Price and Gross Margin of APS Biocontrol Ltd. (APS)
12.11 Qingdao Phagepharm Bio-tech
12.11.1 Company profile
12.11.2 Representative Phage Therapy Product
12.11.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Qingdao Phagepharm Bio-tech
12.12 Fixed-Phage Limited
12.12.1 Company profile
12.12.2 Representative Phage Therapy Product
12.12.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Fixed-Phage Limited
12.13 Zeptometrix
12.13.1 Company profile
12.13.2 Representative Phage Therapy Product
12.13.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Zeptometrix
12.14 Phage International, Inc.
12.14.1 Company profile
12.14.2 Representative Phage Therapy Product
12.14.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Phage International, Inc.
12.15 MicroMir
12.15.1 Company profile
12.15.2 Representative Phage Therapy Product
12.15.3 Phage Therapy Sales, Revenue, Price and Gross Margin of MicroMir
12.16 iNtODEWORLD, Inc.
12.17 NEXTBIOTICS
12.18 Armata Pharmaceuticals, Inc.
12.19 Innophage
12.20 Adaptive Phage Therapeutics
12.21 TechnoPhage
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PHAGE THERAPY
13.1 Industry Chain of Phage Therapy
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PHAGE THERAPY
14.1 Cost Structure Analysis of Phage Therapy
14.2 Raw Materials Cost Analysis of Phage Therapy
14.3 Labor Cost Analysis of Phage Therapy
14.4 Manufacturing Expenses Analysis of Phage Therapy
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Phage Therapy in This Report
1.2 Commercial Types of Phage Therapy
1.2.1 DsDNA Bacteriophage
1.2.2 SsDNA Bacteriophage
1.2.3 SsRNA Bacteriophage
1.2.4 Others
1.3 Downstream Application of Phage Therapy
1.3.1 Animal Health
1.3.2 Aquaculture
1.3.3 Agriculture
1.3.4 Food Industry
1.3.5 Human Health
1.3.6 Others
1.4 Development History of Phage Therapy
1.5 Market Status and Trend of Phage Therapy 2016-2026
1.5.1 Global Phage Therapy Market Status and Trend 2016-2026
1.5.2 Regional Phage Therapy Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Phage Therapy 2016-2021
2.2 Sales Market of Phage Therapy by Regions
2.2.1 Sales Volume of Phage Therapy by Regions
2.2.2 Sales Value of Phage Therapy by Regions
2.3 Production Market of Phage Therapy by Regions
2.4 Global Market Forecast of Phage Therapy 2022-2026
2.4.1 Global Market Forecast of Phage Therapy 2022-2026
2.4.2 Market Forecast of Phage Therapy by Regions 2022-2026
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Phage Therapy by Types
3.2 Sales Value of Phage Therapy by Types
3.3 Market Forecast of Phage Therapy by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Phage Therapy by Downstream Industry
4.2 Global Market Forecast of Phage Therapy by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Phage Therapy Market Status by Countries
5.1.1 North America Phage Therapy Sales by Countries (2016-2021)
5.1.2 North America Phage Therapy Revenue by Countries (2016-2021)
5.1.3 United States Phage Therapy Market Status (2016-2021)
5.1.4 Canada Phage Therapy Market Status (2016-2021)
5.1.5 Mexico Phage Therapy Market Status (2016-2021)
5.2 North America Phage Therapy Market Status by Manufacturers
5.3 North America Phage Therapy Market Status by Type (2016-2021)
5.3.1 North America Phage Therapy Sales by Type (2016-2021)
5.3.2 North America Phage Therapy Revenue by Type (2016-2021)
5.4 North America Phage Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Phage Therapy Market Status by Countries
6.1.1 Europe Phage Therapy Sales by Countries (2016-2021)
6.1.2 Europe Phage Therapy Revenue by Countries (2016-2021)
6.1.3 Germany Phage Therapy Market Status (2016-2021)
6.1.4 UK Phage Therapy Market Status (2016-2021)
6.1.5 France Phage Therapy Market Status (2016-2021)
6.1.6 Italy Phage Therapy Market Status (2016-2021)
6.1.7 Russia Phage Therapy Market Status (2016-2021)
6.1.8 Spain Phage Therapy Market Status (2016-2021)
6.1.9 Benelux Phage Therapy Market Status (2016-2021)
6.2 Europe Phage Therapy Market Status by Manufacturers
6.3 Europe Phage Therapy Market Status by Type (2016-2021)
6.3.1 Europe Phage Therapy Sales by Type (2016-2021)
6.3.2 Europe Phage Therapy Revenue by Type (2016-2021)
6.4 Europe Phage Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Phage Therapy Market Status by Countries
7.1.1 Asia Pacific Phage Therapy Sales by Countries (2016-2021)
7.1.2 Asia Pacific Phage Therapy Revenue by Countries (2016-2021)
7.1.3 China Phage Therapy Market Status (2016-2021)
7.1.4 Japan Phage Therapy Market Status (2016-2021)
7.1.5 India Phage Therapy Market Status (2016-2021)
7.1.6 Southeast Asia Phage Therapy Market Status (2016-2021)
7.1.7 Australia Phage Therapy Market Status (2016-2021)
7.2 Asia Pacific Phage Therapy Market Status by Manufacturers
7.3 Asia Pacific Phage Therapy Market Status by Type (2016-2021)
7.3.1 Asia Pacific Phage Therapy Sales by Type (2016-2021)
7.3.2 Asia Pacific Phage Therapy Revenue by Type (2016-2021)
7.4 Asia Pacific Phage Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Phage Therapy Market Status by Countries
8.1.1 Latin America Phage Therapy Sales by Countries (2016-2021)
8.1.2 Latin America Phage Therapy Revenue by Countries (2016-2021)
8.1.3 Brazil Phage Therapy Market Status (2016-2021)
8.1.4 Argentina Phage Therapy Market Status (2016-2021)
8.1.5 Colombia Phage Therapy Market Status (2016-2021)
8.2 Latin America Phage Therapy Market Status by Manufacturers
8.3 Latin America Phage Therapy Market Status by Type (2016-2021)
8.3.1 Latin America Phage Therapy Sales by Type (2016-2021)
8.3.2 Latin America Phage Therapy Revenue by Type (2016-2021)
8.4 Latin America Phage Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Phage Therapy Market Status by Countries
9.1.1 Middle East and Africa Phage Therapy Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Phage Therapy Revenue by Countries (2016-2021)
9.1.3 Middle East Phage Therapy Market Status (2016-2021)
9.1.4 Africa Phage Therapy Market Status (2016-2021)
9.2 Middle East and Africa Phage Therapy Market Status by Manufacturers
9.3 Middle East and Africa Phage Therapy Market Status by Type (2016-2021)
9.3.1 Middle East and Africa Phage Therapy Sales by Type (2016-2021)
9.3.2 Middle East and Africa Phage Therapy Revenue by Type (2016-2021)
9.4 Middle East and Africa Phage Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PHAGE THERAPY
10.1 Global Economy Situation and Trend Overview
10.2 Phage Therapy Downstream Industry Situation and Trend Overview
CHAPTER 11 PHAGE THERAPY MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Phage Therapy by Major Manufacturers
11.2 Production Value of Phage Therapy by Major Manufacturers
11.3 Basic Information of Phage Therapy by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Phage Therapy Major Manufacturer
11.3.2 Employees and Revenue Level of Phage Therapy Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PHAGE THERAPY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 NPO Microgen
12.1.1 Company profile
12.1.2 Representative Phage Therapy Product
12.1.3 Phage Therapy Sales, Revenue, Price and Gross Margin of NPO Microgen
12.2 Proteon Pharmaceuticals
12.2.1 Company profile
12.2.2 Representative Phage Therapy Product
12.2.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Proteon Pharmaceuticals
12.3 Phagelux
12.3.1 Company profile
12.3.2 Representative Phage Therapy Product
12.3.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Phagelux
12.4 Intralytix
12.4.1 Company profile
12.4.2 Representative Phage Therapy Product
12.4.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Intralytix
12.5 Micreos
12.5.1 Company profile
12.5.2 Representative Phage Therapy Product
12.5.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Micreos
12.6 Eliava BioPreparations
12.6.1 Company profile
12.6.2 Representative Phage Therapy Product
12.6.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Eliava BioPreparations
12.7 Locus Biosciences,Inc
12.7.1 Company profile
12.7.2 Representative Phage Therapy Product
12.7.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Locus Biosciences,Inc
12.8 Pharmex Group,LLC
12.8.1 Company profile
12.8.2 Representative Phage Therapy Product
12.8.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Pharmex Group,LLC
12.9 Pherecydes Pharma
12.9.1 Company profile
12.9.2 Representative Phage Therapy Product
12.9.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Pherecydes Pharma
12.10 APS Biocontrol Ltd. (APS)
12.10.1 Company profile
12.10.2 Representative Phage Therapy Product
12.10.3 Phage Therapy Sales, Revenue, Price and Gross Margin of APS Biocontrol Ltd. (APS)
12.11 Qingdao Phagepharm Bio-tech
12.11.1 Company profile
12.11.2 Representative Phage Therapy Product
12.11.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Qingdao Phagepharm Bio-tech
12.12 Fixed-Phage Limited
12.12.1 Company profile
12.12.2 Representative Phage Therapy Product
12.12.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Fixed-Phage Limited
12.13 Zeptometrix
12.13.1 Company profile
12.13.2 Representative Phage Therapy Product
12.13.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Zeptometrix
12.14 Phage International, Inc.
12.14.1 Company profile
12.14.2 Representative Phage Therapy Product
12.14.3 Phage Therapy Sales, Revenue, Price and Gross Margin of Phage International, Inc.
12.15 MicroMir
12.15.1 Company profile
12.15.2 Representative Phage Therapy Product
12.15.3 Phage Therapy Sales, Revenue, Price and Gross Margin of MicroMir
12.16 iNtODEWORLD, Inc.
12.17 NEXTBIOTICS
12.18 Armata Pharmaceuticals, Inc.
12.19 Innophage
12.20 Adaptive Phage Therapeutics
12.21 TechnoPhage
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PHAGE THERAPY
13.1 Industry Chain of Phage Therapy
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PHAGE THERAPY
14.1 Cost Structure Analysis of Phage Therapy
14.2 Raw Materials Cost Analysis of Phage Therapy
14.3 Labor Cost Analysis of Phage Therapy
14.4 Manufacturing Expenses Analysis of Phage Therapy
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
